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  An experimental study was made using dogs with cutaneous ureterostomy i’n order to
elucidate the significance of concentration in urine of an antibiotic for urinary tract infection，
The antibiotic chosen was cephaloridine （CER）．
  1． lt was proved that CER in the vesical urine was mostly of renal origin and partly of
vesical tissue origin．
  2， 〈）Qncentration of CER in the vesical tissue was higher in the intact dog＃ than in the
dogs with ureterostomy． This su，ggests that the antib！otic in the bladder tissue originates from
the blood as well as from the urine in the bladder．
  3．Implantation of the ce工lulose tube containing E． coli was皿ade both on the control dogs
and dogs with ureterostomy． ln the former group， pretty high concentration of CER was proved
in the tube in 4 hours resulting in disappearance of the microorganism． ln the latter group，
however， microorganism decreased but persisted．
  4． Experimenta／ cystitis was made both in the control dogs and’ dogs with ureterostomy，
and CER was administered intravenously． The microorganis皿in the in且ammatory vesical
tissue was followed by means of bioautography， lnhibition of the growth was observed in 12
hours in the former group but not in the latter group even at 48 hours．
  From the above results， concentration of the antibiotics in urine is of great importance，
therefo’re， an antibiotic of choice should be such as one having high urinary excretion rate．
On the other hand， the antibiotic in the vesical tissue cannot be ignored because the site of

































   生菌の種類


































     膀胱側右尿管にネラトンチューブを挿入
 方 法：CERO．5，1．Og静脈内投与
     ネラトンチューブより正常下戸を尿管より
     流出する尿と同じ速度で膀胱へ注入























Table 1．尿管と膀胱より排泄される抗生物質濃度 CER O．5g静注投与
！ 2 tl， 6 8 総排泄量
    尿管尿
No． 1    膀胱事
解          量38！cc 228 mg   165 m9
注入したイヌ尿量558  0    0
67．2mg i 56．7rng 1 42．1mg I 559．O

























































Table 2．膀胱組織内濃度 CER l g 1回静注
粛週遡！ 6 12
尿管皮膚巨群 2． 04 mcg／g1 ． 81 mcg／g
無処置群 ！O． 58 mcg／g1 1 ． 00 mcg／g
O． 3s mcg／g
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Fig， 2．

























     物質濃度         mcg／ml
Table 4．セルローズチューブ内菌定量培養
          寒天平板 17時間培養
藩一一一脚｝・ 12 24 、。mplr一曲遡｝・
   A tube
   B tube



















     使用菌：尿路感染分離E． Col t
∠1｝・織セル・一伽齪量，・薬





























    霧｝騰蹴膀漁
Fig．4．イヌ膀胱内に植え込んだセルローズチューブ
    内の菌の増殖状態
















































     二七群における膀胱内へ植え込んだセ
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 すなわち①Pseudomonas aeruginosa Tsuchijima，
②Klebsie〃σSP No．13，③E． coli 078，④Proteecs
mirabilis P－74，⑤Proteecs vu／ga／is P－49，⑥Proteus






 staining の良さは E． coli StaPhylOCOCCUS















Photo．1．濾紙および腎切片上のE． coliのstaining． Photo．2． CER未投与時のbioautogram
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    滅菌蒸留水でよく洗浄
    尿路感染症例より分離したE．coli培養液
    を30cc注入し3日間血膿尿，頻尿の状態を
    観察してから各実験に使用
使用菌：尿路感染症より分離した菌E．coli
    各種抗生物質に対するMIC
     CER 6．2s mcg／ml．KM 12．s mcg／ml
     AB－PC 3．13mcg／ml．CP 12．smcg／ml















































































































1．84 mcg／g，12時間後0．35 mcg／g，1．55 mcg／gと組
織内濃度は低かった．無処置群では6時間10．58nlcg





























































 すなわちTubaroおよびBulgini eX Staphylococ．















Tuchijima， Klebsiella SP－No． 13， E． coli 078，
Proteus mirabilis P74， Proteus veclgaris P－49，
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